MTOR and tuberous sclerosis: TSC cutaneous lesions are not life-threatening, but they strongly affect the quality of life of patients and, applying the state of the art methods, the approved treatments (mainly surgery and topical administration of mTOR inhibitors) do not prevent their recurrence [6].